The Food and Drug Administration on Friday expanded the use of Gardasil 9, Merck’s vaccine against the human papillomavirus (HPV), to adults up to age 45.
The Food and Drug Administration on Friday expanded the use of Gardasil 9, Merck’s vaccine against the human papillomavirus (HPV), to adults up to age 45.